BIRMINGHAM, Ala., May 6, 2019 /PRNewswire/ -- Encompass Health Corporation (EHC) today issued notice for redemption of $100 million of the outstanding principal balance of its 5.75% senior notes due 2024 (the "2024 Notes"). Pursuant to the terms of the 2024 Notes, this optional partial redemption will be made at a price of 101.917%. The Company plans to use cash on hand and capacity under its revolving credit facility to fund the redemption, which will close on June 7, 2019. As a result of this redemption, the Company expects to record an approximate $2 million loss on early extinguishment of debt in the second quarter of 2019.
About Encompass Health
As a national leader in integrated healthcare services, Encompass Health (EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 130 hospitals, 221 home health locations, and 59 hospice locations in 37 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter and Facebook.
Statements contained in this press release which are not historical facts are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including its pending DOJ and HHS-OIG investigations and any matters related to yet undiscovered issues, if any, at acquired companies; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2018 and Form 10-Q for the quarter ended March 31, 2019.
Hillary Carnel | 205.970-5912
Investor Relations Contact:
Crissy Carlisle | 205.970.5860
View original content to download multimedia:http://www.prnewswire.com/news-releases/encompass-health-issues-notice-for-redemption-of-100-million-of-its-5-75-senior-notes-due-2024--300844618.html